Cargando…
The SR-B1 Receptor as a Potential Target for Treating Glioblastoma
PURPOSE: The goal of these studies was to provide proof of concept for a novel targeted therapy for Glioblastoma Multiforme (GBM). Methods. These studies involve the evaluation of reconstituted high density lipoprotein (rHDL) nanoparticles (NPs) as delivery agents for the drug, mammalian Target of R...
Autores principales: | Berney, Ethan, Sabnis, Nirupama, Panchoo, Marlyn, Raut, Sangram, Dickerman, Rob, Lacko, Andras G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583082/ https://www.ncbi.nlm.nih.gov/pubmed/31275377 http://dx.doi.org/10.1155/2019/1805841 |
Ejemplares similares
-
Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
por: Mooberry, Linda K., et al.
Publicado: (2016) -
Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery
por: Sabnis, Sarika, et al.
Publicado: (2017) -
SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
por: Johnson, Rebecca, et al.
Publicado: (2017) -
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018) -
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
por: Johnson, Rebecca, et al.
Publicado: (2013)